CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Common Stock Restricted stock units	Additional Paid-In Capital	Accumulated Deficit
Balances (in shares) at Dec. 31, 2021		44,640,000
Balances at Dec. 31, 2021	$ 102,414	$ 4		$ 531,636	$ (429,226)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in conjunction with vesting of restricted stock units, net of employee's withholding liability (in shares)			307,000
Issuance of common stock in conjunction with vesting of restricted stock units, net of employee's withholding liability	(598)			(598)
Issuance of common stock upon exercise of warrant (in shares)		388,000
Stock-based compensation	982			982
Net income (loss) and comprehensive income (loss)	9,064				9,064
Net income and comprehensive income	9,064
Balances (in shares) at Mar. 31, 2022		45,335,000
Balances at Mar. 31, 2022	$ 111,862	$ 4		532,020	(420,162)
Balances (in shares) at Dec. 31, 2022	48,319,838	48,320,000
Balances at Dec. 31, 2022	$ 225,725	$ 5		545,321	(319,601)
Increase (Decrease) in Stockholders' Equity
Induced exchange of convertible notes (in shares)		6,990,000
Induced exchange of convertible notes (See Note 9)	26,699			26,699
Issuance of common stock in conjunction with vesting of restricted stock units, net of employee's withholding liability (in shares)			352,000
Issuance of common stock in conjunction with vesting of restricted stock units, net of employee's withholding liability	(722)			(722)
Stock-based compensation	2,446			2,446
Net income (loss) and comprehensive income (loss)	(3,484)				(3,484)
Net income and comprehensive income	$ (3,484)
Balances (in shares) at Mar. 31, 2023	55,661,866	55,662,000
Balances at Mar. 31, 2023	$ 250,664	$ 5		$ 573,744	$ (323,085)